Skip to main content

Shukra Pharmaceuticals Share Price

SHUKRAMED

Small Cap | Pharmaceuticals

₹ 81.60

-0.60(0.73%)
Price as of 20 Nov 2026 09:44. Log in to view Live prices

Shukra Pharmaceuticals Share Price Chart

Shukra Pharmaceuticals Performance

Days Range

Low: ₹80.30

High: ₹83.40

Previous Close₹82.22
Open₹81.00
Volume3,85,730
Day's Range₹80.30 - ₹83.40
52W Range₹40.06 - ₹84.80
Market Cap₹3,638.42 Cr

Shukra Pharmaceuticals Fundamentals

ROCE(TTM)45.74
P/E Ratio (TTM)82.22
P/B Ratio29.17
Industry P/E40.36
Debt to Equity0.19
ROE37.38
EPS (TTM)1
Dividend Yield0.01
Book Value2.82
Face Value1
ROCE(TTM)45.74
P/E Ratio (TTM)82.22
P/B Ratio29.17
Industry P/E40.36
Debt to Equity0.19
ROE37.38
EPS (TTM)1
Dividend Yield0.01
Book Value2.82
Face Value1

Shukra Pharmaceuticals Financials

Dec 2025Mar 2026Jun 2026Sep 2026
Net Sales39.136.3223.5244.20
Expenses12.846.635.4626.62
Profit before tax26.830.3818.1717.83
Operating Profit20.36-1.7212.9612.71
Net Profit20.36-1.7212.9612.71
EPS in Rs0.47-0.040.300.29

Shukra Pharmaceuticals Shareholding Pattern

Promoters
51.15%
Retail And Others
48.20%
Foreign Institutional Investors
0.44%
Domestic Institutional Investors
0.22%

About Shukra Pharmaceuticals

Relish Pharmaceuticals Ltd is a public limited company with a global perspective, manufacturing, exporting and marketing in both domestic and international markets. The company was incorporated on March 4, 1993 as a private limited company with the name Relish Pharmaceuticals Pvt Ltd. In August 31, 1993, the company was converted into a public limited company and the name was changed to Relish Pharmaceuticals Ltd. The company provides varieties of products to the clientele. Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others. The company has four manufacturing divisions namely tablets (General and Beta Lactum) Capsules (General and Beta Lactum), Liquid and small volume parental. Their manufacturing unit is located at Rakanpur in Gujarat. The company customers include leading Manufacturers like Cadila Healthcare Limited (Zydus), Intas Pharmaceuticals Limited, Cadila Pharmaceuticals Limited, Makers Laboratories Limited, Agenta Pharma Limited etc. The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceuticals companies around the world.

Parent Organisation
Indian Private
Managing Director
Dakshesh Shah
Founded
1993
NSE Symbol
SHUKRAMED

Shukra Pharmaceuticals Share Price History

Data is not available currently. Please check back later.

Top Mutual Funds Invested in Shukra Pharmaceuticals Share

Data is not available currently. Please check back later.

Peer Comparison

StocksLTP (₹)Market Cap (cr)52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd1,891.5Price decrease
-8.50 (-0.45%)
₹4,56,593.441,583.7 - 2,046.9
Divis Laboratories Ltd11,050.0Price decrease
-128.00 (-1.15%)
₹2,96,740.785,647.5 - 11,824.0
Torrent Pharmaceuticals Ltd4,639.5Price increase
28.50 (0.62%)
₹1,75,577.803,672.3 - 5,250.0
Laurus Labs Ltd2,302.9Price decrease
-3.10 (-0.13%)
₹1,24,379.87917.95 - 2,488.0
Zydus Lifesciences Ltd1,197.9Price decrease
-5.00 (-0.42%)
₹1,19,700.46835.5 - 1,266.6
Dr Reddys Laboratories Ltd1,391.0Price decrease
-9.90 (-0.71%)
₹1,16,770.961,101.0 - 1,414.9

Shukra Pharmaceuticals Ltd FAQs

Yes, You can buy Shukra Pharmaceuticals Ltd (SHUKRAMED) shares by opening a Demat account with Angel One.
Shukra Pharmaceuticals Ltd (SHUKRAMED) share can be bought through the following modes:
1. Direct investment: You can buy Shukra Pharmaceuticals Ltd (SHUKRAMED) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Shukra Pharmaceuticals Ltd (SHUKRAMED) shares.